Targeting the renin–angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

By Kjeldsen Sverre E   Lyle Paulette A   Tershakovec Andrew M   Devereux Richard B   Oparil Suzanne   Dahlöf Björn   de Faire Ulf   Fyhrquist Frej   Ibsen Hans   Kristianson Krister   Lederballe-Pedersen Ole   Lindholm Lars H   Nieminen Markku S   Omvik Per   Wedel Hans  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 729-745

Informa Healthcare

Access to resources Recommend Favorite

Advances in Angiotensin Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs)

By  

Mini Reviews in Medicinal Chemistry, Vol. 3, Iss. 6, 2003-09 ,pp. : 621-631

Bentham Science Publishers

Access to resources Recommend Favorite

Renin-angiotensin System Blockade at the Level of the Angiotensin Converting Enzyme or the Angiotensin Type-1 Receptor: Similarities and Differences

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 4, 2004-01 ,pp. : 473-481

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin–angiotensin system: a patent review

By Ferreira Anderson J   Bader Michael   Santos Robson AS  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 567-574

Informa Healthcare

Access to resources Recommend Favorite

Tolerability of Angiotensin-Receptor Blockers in Patients with Intolerance to Angiotensin-Converting Enzyme Inhibitors: A Systematic Review and Meta-Analysis

By Caldeira Daniel   David Cláudio   Sampaio Cristina  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 4, 2012-08 ,pp. : 263-277

Adis International

Access to resources Recommend Favorite